Neostigmine

Overview

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Neostigmine's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

0.02 mg/ kg0.02 (0.02)As recommended.IMFor diagnosis of myasthenia gravis
0.5 to 2.5 mg1.5 (1.5)As recommended.IV, IM, SCAdditional doses depend upon the patient response. Max. 10mg/day
75 to 300 mg190 (187.5)4 hourlyPOMax. 180mg/day
500 ug500 (500)4 hourlyPO,S/C,IMFor paralytic ileus & postperative urinary retention.

Paedriatic Dosage (20kg)

50 to 0 ug/kg25 (25)As recommended.Intra VenousTo severe neuromuscular blockade.
200 to 0 mg/kg100 (100)6 hourlyOralFor Myasthenia grains.

Neonatal Dosage (3kg)

50 ug/kg50 (50)As recommended.IntravenousAs required
0.5 to 1 mg/kg0.75 (0.75)6 hourlyOralFor all ages

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Neostigmine

Back to top

Manufacturers of Neostigmine in Pakistan

Akhai Brookes Caraway Elite Fassgen Global Goodman Haji Indus Mass Neutro Siza

Back to top

Previous Drug Generic - Next Drug Generic